InsidersTradesSigma
Browse the full record of transactions filed by Gladstone Michael, Director. Officer active across 1 company, notably Day One Biopharmaceuticals, Inc.. Aggregated, 1 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €10.9m. History available since 17 June 2022. The latest transaction was disclosed on 17 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Michael Gladstone is a Board Member at Day One Biopharmaceuticals, Inc. He is involved in overseeing the company's operations and implementing its strategy. His expertise in the biopharmaceutical sector is a valuable asset for the organization.